Viewing Study NCT01240720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:04 AM
Study NCT ID: NCT01240720
Status: COMPLETED
Last Update Posted: 2014-02-25
First Post: 2010-10-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer
Sponsor: Philogen S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module